Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gabapentin for Insomnia and VMS in Menopause
NCT02040532Completed
- Sponsor
- Massachusetts General Hospital
- Start
- Jan 2014
- Primary completion
- Aug 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of gabapentin in Insomnia and vasomotor symptoms, sponsored by Massachusetts General Hospital. Primary endpoints: Tolerability of Gabapentin at Week 7, Reason for Non-tolerability and Discontinuation of Gabapentin at Week 7 and 4 more. Started Jan 2014; status: completed.
02
Drugs
gabapentin
03
Conditions
Insomniavasomotor symptoms
Beyond the preview
Go deeper on NCT02040532.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02040532.